The North America Gemcitabine Market is influenced by the availability of generic medicines and healthcare cost-management priorities. Reliable manufacturing and distribution are important for maintaining access to injectable chemotherapy products across the region. The Gemcitabine Market size is expected to reach US$ 1,370.48 million by 2034 from US$ 865.06 million in 2025, registering a CAGR...